Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy

NCT01648517 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Carcinoma

Interventions

DRUG: chemotherapy
DRUG: chemotherapy

Sponsor

Yonsei University